Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

BioLineRx (BLRX) Return on Assets (2023 - 2025)

Historic Return on Assets for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to 0.33%.

  • BioLineRx's Return on Assets rose 2200.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year increase of 2200.0%. This contributed to the annual value of 0.38% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, BioLineRx's Return on Assets is 0.33%, which was up 2200.0% from 0.36% recorded in Q2 2025.
  • In the past 5 years, BioLineRx's Return on Assets ranged from a high of 0.33% in Q3 2025 and a low of 0.81% during Q4 2023
  • For the 3-year period, BioLineRx's Return on Assets averaged around 0.55%, with its median value being 0.5% (2024).
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 3600bps in 2024, then skyrocketed by 2200bps in 2025.
  • BioLineRx's Return on Assets (Quarter) stood at 0.81% in 2023, then soared by 44bps to 0.45% in 2024, then grew by 27bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q3 2025, 0.36% for Q2 2025, and 0.42% during Q1 2025.